Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
Abstract Background Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for opioid use disorder (MOUD; e.g., buprenorphine) are...
Saved in:
Main Authors: | Katherine A. Hirchak (Author), Solmaz Amiri (Author), Gordon Kordas (Author), Oladunni Oluwoye (Author), Abram J. Lyons (Author), Kelsey Bajet (Author), Judith A. Hahn (Author), Michael G. McDonell (Author), Aimee N. C. Campbell (Author), Kamilla Venner (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Provider perspectives on the impact of COVID-19 on treatment of substance use and opioid use disorders among American Indian and Alaska Native adults
by: Meenakshi Richardson, et al.
Published: (2024) -
Buprenorphine Waiver Attitudes Among Primary Care Providers
by: Benjamin Lai, et al.
Published: (2022) -
An unexplored equity factor: differential beliefs and attitudes toward contingency management by providers' ethnicity
by: Oladunni Oluwoye, et al.
Published: (2023) -
Coming together for something good: recommendations from a scoping review for dissemination and implementation science to improve indigenous substance use disorder treatment
by: Katherine A. Hirchak, et al.
Published: (2023) -
Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US
by: Berkeley Franz, et al.
Published: (2023)